Viscoelastic-related glaucomas.
The routine surgical use of viscoelastic substances has revolutionized many anterior segment procedures. All of the currently available agents may be responsible for causing or exacerbating a transient, but occasionally significant, postoperative IOP elevation. In spite of differences in physical properties such as molecular weight, concentration, and viscosity, none of the various viscoelastics has consistently shown a decreased likelihood of producing ocular hypertension. Moreover, any newly introduced product must be evaluated carefully for this potential complication. Lavage of viscomaterial from the anterior chamber and administration of ocular antihypertensives may be helpful in averting or controlling the increased IOP. The surgeon should be cognizant of any pre-existing optic nerve damage and adjust the aggressiveness of postoperative glaucoma therapy accordingly. In the future, the development of new substances or simultaneous use of degrading enzymes may reduce or eliminate the incidence of viscoelastic-induced ocular hypertension.
Morgan
R K
RK
Dean A. McGee Eye Institute, Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
Skuta
G L
GL
D000818:Animals; D000869:Anterior Eye Segment / Q000601:surgery; D002807:Chondroitin / Q000009:adverse effects* / Q000627:therapeutic use; D005901:Glaucoma / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D007429:Intraocular Pressure; D009798:Ocular Hypertension / Q000139:chemically induced* / Q000517:prevention & control; D011183:Postoperative Complications